FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Amgen related Press Releases

Amgen to Acquire Micromet

Posted January 26, 2012

Amgen to Acquire Micromet Acquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies Micromet's Proprietary BiTE® Platform has Potential to Improve Treatment in Read more...

Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results

Posted January 24, 2012

THOUSAND OAKS, Calif., Jan. 24, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2011 financial results on Thursday, Jan. 26, 2012 after Read more...

Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director

Posted January 11, 2012

OXFORD, England, January 11, 2012 /PRNewswire/ -- Oxford BioTherapeutics (OBT) today announces that it has appointed C. Glenn Begley as a senior clinical advisor and non-executive director. Dr Read more...

Zymeworks Announces the Formation of its Therapeutics Advisory Team, and Appointment of VP, Preclinical R&D to Advance its

Posted January 5, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based Read more...

Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference

Posted January 4, 2012

THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, Read more...

Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Co

Posted December 15, 2011

Roger Perlmutter to Retire as EVP of Research and Development with Sean Harper to Assume the Role on February 13, 2012 THOUSAND OAKS, Calif., Dec. 15, 2011 /PRNewswire/ -- Kevin W. Sharer, chairman Read more...

Amgen Announces 2012 First Quarter Dividend

Posted December 15, 2011

THOUSAND OAKS, Calif., Dec. 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directors today declared a $0.36 per share dividend for the first quarter of 2012. This Read more...

Amgen Statement on European Investor Visit

Posted November 14, 2011

THOUSAND OAKS, Calif., Nov. 14, 2011 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement: Amgen will be meeting with investors in Europe this week with a view to raise $1-1.5 Read more...

Micromet to Report Third Quarter 2011 Financial Results on November 8

Posted October 24, 2011

ROCKVILLE, Md.--(BUSINESS WIRE)-- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of Read more...

ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2012 Financial Results

Posted October 20, 2011

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the Company will host a Read more...
123456789…next ›last »